2041 Dynamic Screening Nutritional Risk Index on Treatment Tolerance and Hospitalization Costs in Cancer Patient: A 3-Year Longitudinal Cohort Study Hongfan Yu 1 , Li Tang 2 , Qiuling Shi 1 , Xing Wei 3 1 State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing, China, 2 Shaoxing Second Hospital, Shaoxing, China, 3 Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of the University of Electronic Science and Technology of China, Chengdu, China Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :2041 Aims Assessment of the advanced cancer patient developing malnutrition has been limited to cross-sectional design
It also has a variety of over-the-counter health supplements, a 3D body scanner for clients to check their progress and be informed about their bodys specific needs, as well as telehealth services
Obesity and reproduction: A committee opinion
When would a provider add an oral DPP-4 rather than raising the GLP-1
Alternative medications to Orforglipron While Orforglipron is not yet available, several other GLP-1 medications are FDA-approved for weight loss and type 2 diabetes treatment
